Symbol not found

:EMIS   00:00AM GMT
0.00
0.00 (0.00%)
Equity Investments, Other Pre-Announcement, Mergers / Acquisitions

Novo Nordisk To Acquire Emisphere Technologies

Published: 11/06/2020 06:41 GMT
(EMIS) - Novo Nordisk to Acquire Emisphere Technologies and Obtain Ownership of the Eligen® Snac Oral Delivery Technology.
Novo Nordisk - Entered Into a Definitive Agreement to Acquire Emisphere Technologies Inc.novo Nordisk - Total Acquisition Price is USD 1.8 Billion.
Novo Nordisk - Under Terms of Agreement, Novo Nordisk Will Acquire All Outstanding Shares of Emisphere for USD 1.350 Billion.
Novo Nordisk - Transaction Will Be Debt Financed and Will Not Impact Novo Nordisk's Previously Communicated Operating Profit Outlook for 2020 Or Ongoing Share Buyback Programme.
Novo Nordisk - Will Also Acquire Related Eligen Snac Royalty Stream Obligations Owed to Mhr Fund Management Llc (mhr), Largest Shareholder of Emisphere, for USD 450 Million.
Novo Nordisk - Acquisition is Expected to Have a Net Negative Impact on Operating Profit of Less Than One Percent in 2021 and Broadly Neutral to Positive Impact in Following Years.